Infrastructure bill, Russia issues keep lobbying revenues high
Some in the industry expected lobbying spending to level out ahead of the midterms and after numerous pandemic relief bills and the initial burst that a new administration provides.
Stay updated with breaking news from Acceleron Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Some in the industry expected lobbying spending to level out ahead of the midterms and after numerous pandemic relief bills and the initial burst that a new administration provides.
This randomized clinical trial compares the efficacy and adverse effects of the 3 most frequently prescribed corticosteroid regimens for boys with Duchenne musc
/PRNewswire/ -- The "Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2021" report has been added to...
/PRNewswire/ -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), a development-stage biotechnology company pioneering the first systematic approach to use...
Will 2021's trend of high volume but small value merger and acquisition (M&A) deals continue in 2022? Subin Baral, EY Global Life Sciences Deals Leader discusses what is motivating the recent changes in M&A contracts.